In Brief: AHCPR PSA study
This article was originally published in The Gray Sheet
AHCPR PSA study: Agency for Health Care Policy and Research is seeking information on prostate-specific antigen test utility, costs, specific indications and appropriate patient population for a review of past, current and planned research related to PSA testing. According to a Dec. 22 Federal Register notice, AHCPR plans to make a recommendation following completion of the assessment to the Health Care Financing Administration regarding a Medicare coverage policy for the test...
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.